DEBORAH HIRT: Open Payments
NPI 1992896716 · DELMAR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 19 payments from 13 companies in 2025. Trend: 2023 $120 · 2024 $248 · 2025 $1,055
Food & beverage: $1,055
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $126 |
| Novo Nordisk Inc | 1 | $123 |
| Ultragenyx Pharmaceutical Inc. | 1 | $123 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $121 |
| Neurelis, Inc. | 1 | $113 |
| CVRx, Inc. | 1 | $104 |
| ABIOMED | 1 | $93 |
| Exeltis, USA Inc. | 4 | $80 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
Products named: INVEGA SUSTENNA, Wegovy, VALTOCO, Barostim Neo System, SLYND, MYFEMBREE, Veozah, FEMLYV.
Industry payments across NY — which companies pay providers there.
